Aptose Biosciences (TSE:APS) Stock Passes Above 50-Day Moving Average – Time to Sell?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO)’s stock price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$2.21 and traded as high as C$2.25. Aptose Biosciences shares last traded at C$2.25, with a volume of 3,066 shares changing hands.

Aptose Biosciences Stock Down 0.4%

The firm has a fifty day moving average of C$2.21 and a 200-day moving average of C$2.05. The company has a quick ratio of 5.41, a current ratio of 0.53 and a debt-to-equity ratio of -97.77. The firm has a market cap of C$5.74 million, a P/E ratio of 3.26 and a beta of -1.19.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma.